Guardant Health, Inc.
GH Healthcare Diagnostics & Research
Guardant Health, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $982.0 million, up 32.9% from fiscal 2024.
- Revenue
- +36.1%
- EPS
- −25.7%
- Free cash flow
- +18.7%
- Total debt
- +34.8%
Quarter to September 2026, against a year earlier
Follow GH
Alert me
Guardant Health, Inc. (GH) Current ratio
Guardant Health, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 3.6×, down 1.2× from fiscal 2025 (4.8×). Over the past ten years it has ranged from 4.7× (fiscal 2024) to 28.3× (fiscal 2020); the current reading is higher than 20% of that period. That is above the Diagnostics & Research industry median of 2.3× and above the Healthcare sector median of 3.1×.
Current ratio, annual
Embed this chart
Annual newest first
| Period | Current ratio | Change |
|---|---|---|
| FY2025 | 4.8× | 3.54% |
| FY2024 | 4.7× | (28.50%) |
| FY2023 | 6.5× | 6.08% |
| FY2022 | 6.2× | 7.76% |
| FY2021 | 5.7× | (79.75%) |
| FY2020 | 28.3× | 244.15% |
| FY2019 | 8.2× | (17.79%) |
| FY2018 | 10.0× | (19.29%) |
| FY2017 | 12.4× | 68.24% |
| FY2016 | 7.4× | — |
Quarterly newest first
| Period | Current ratio | Change |
|---|---|---|
| Sep 2026 | 3.6× | (10.58%) |
| Jun 2026 | 4.0× | (13.99%) |
| Mar 2026 | 4.7× | (3.34%) |
| Dec 2025 | 4.8× | 38.42% |
| 29 more quarters | Free account |
Against its own ten years
Current ratio against peers
| Company | Current ratio |
|---|---|
| GH Guardant Health, Inc. | 3.6× |
| RVTY Revvity Inc. compare | 2.7× |
| ILMN Illumina, Inc. compare | 2.6× |
| DGX Quest Diagnostics Incorporated compare | 1.7× |
| CRL Charles River Laboratories International, Inc. compare | 1.4× |
| LH Labcorp Holdings Inc. compare | 1.4× |
| ICLR ICON PLC compare | 1.3× |
| MTD Mettler-Toledo International, Inc. compare | 1.1× |
| MEDP Medpace Holdings, Inc. compare | 0.8× |
| Diagnostics & Research industry median | 2.3× |
| Healthcare sector median | 3.1× |
| Market median | 1.6× |
What Current ratio is
Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.
Current Assets (Total) ÷ Current Liabilities (Total)
More on GH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement